Association between DAOA gene polymorphisms and the risk of schizophrenia, bipolar disorder and depressive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 51, Issue , 2014, Pages 89-98

  Tan, Jinjing ^a   Lin, Yu ^b   Su, Li ^b   Yan, Yan ^a   Chen, Qing ^a   Jiang, Haiyun ^a   Wei, Qiugui ^a   Gu, Lian ^a  

^a GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Bipolar disorder; DAOA; Depressive disorder; Schizophrenia; Single nucleotide polymorphism

Indexed keywords

CARRIER PROTEIN; DAOA PROTEIN, HUMAN;

BIPOLAR DISORDER; DEPRESSION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; META ANALYSIS (TOPIC); RISK; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

BIPOLAR DISORDER; CARRIER PROTEINS; DEPRESSIVE DISORDER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; META-ANALYSIS AS TOPIC; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84893539770     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.01.007     Document Type: Article

References (62)

1. Bakker S.C., Hoogendoorn M.L., Hendriks J., Verzijlbergen K., Caron S., Verduijn W., et al. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behav 2007, 6:113-119.
2. Bass N.J., Datta S.R., McQuillin A., Puri V., Choudhury K., Thirumalai S., et al. Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia. Behav Brain Funct 2009, 5:28.
3. Bendikov I., Nadri C., Amar S., Panizzutti R., De Miranda J., Wolosker H., et al. A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia. Schizophr Res 2007, 90:41-51.
4. Buckley P.F., Miller B.J., Lehrer D.S., Castle D.J. Psychiatric comorbidities and schizophrenia. Schizophr Bull 2009, 35:383-402.
5. Chen J., Xu Y., Zhang J., Liu Z., Xu C., Zhang K., et al. Genotypic association of the DAOA gene with resting-state brain activity in major depression. Mol Neurobiol 2012, 46:361-373.
6. Chen J., Xu Y., Zhang J., Liu Z., Xu C., Zhang K., et al. A combined study of genetic association and brain imaging on the DAOA gene in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2013, 162B:191-200.
7. Chen Y.S., Akula N., Detera-Wadleigh S.D., Schulze T.G., Thomas J., Potash J.B., et al. Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33. Mol Psychiatry 2004, 9:87-92. (image 5).
8. Chiesa A., Pae C.U., Porcelli S., Han C., Lee S.J., Patkar A.A., et al. DAOA variants on diagnosis and response to treatment in patients with major depressive disorder and bipolar disorder. J Int Med Res 2012, 40:258-265.
9. Chiesa A., Pae C.U., Porcelli S., Han C., Lee S.J., Patkar A.A., et al. DAOA variants and schizophrenia: influence on diagnosis and treatment outcomes. Int J Psychiatry Clin Med 2011, 15:303-310.
10. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., et al. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 2002, 99:13675-13680.
11. Corvin A., McGhee K.A., Murphy K., Donohoe G., Nangle J.M., Schwaiger S., et al. Evidence for association and epistasis at the DAOA/G30 and d-amino acid oxidase loci in an Irish schizophrenia sample. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:949-953.
12. Dalvie S., Horn N., Nossek C., van der Merwe L., Stein D.J., Ramesar R. Psychosis and relapse in bipolar disorder are related to GRM3, DAOA, and GRIN2B genotype. Afr J Psychiatry 2010, 13:297-301.
13. Gawlik M., Wehner I., Mende M., Jung S., Pfuhlmann B., Knapp M., et al. The DAOA/G30 locus and affective disorders: haplotype based association study in a polydiagnostic approach. BMC Psychiatry 2010, 10:59.
14. Gaysina D., Cohen-Woods S., Chow P.C., Martucci L., Schosser A., Ball H.A., et al. Association analysis of DAOA and DAO in bipolar disorder: results from two independent case-control studies. Bipolar Disord 2010, 12:579-581.
15. Green E.K., Grozeva D., Jones I., Jones L., Kirov G., Caesar S., et al. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 2010, 15:1016-1022.
16. Grigoroiu-Serbanescu M., Herms S., Diaconu C.C., Jamra R.A., Meier S., Bleotu C., et al. Possible association of different G72/G30 SNPs with mood episodes and persecutory delusions in bipolar I Romanian patients. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:657-663.
17. Gu L., Long J., Yan Y., Chen Q., Pan R., Xie X., et al. HTR2A-1438A/G polymorphism influences the risk of schizophrenia but not bipolar disorder or major depressive disorder: a meta-analysis. J Neurosci Res 2013, 91:623-633.
18. Han Y., Ning Q.L., Zhang H., Wang S.H., Zhang F.J., Ma X.H., et al. Correlation between DAOA gene polymorphisms and schizophrenia in the Han Chinese males. Journal of Xi'an Jiaotong University (Medical Sciences). 2010, (5):021.
19. Hattori E., Liu C., Badner J.A., Bonner T.I., Christian S.L., Maheshwari M., et al. Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am J Hum Genet 2003, 72:1131-1140.
20. Hong W., Fang Y.R., Wang Z.W., Qian Y.P., Zhang Q.T., Jiang S.D., et al. Association between depression and G72 gene polymorphism. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2006, 23:532-535.
21. Hukic D.S., Frisen L., Backlund L., Lavebratt C., Landen M., Traskman-Bendz L., et al. Cognitive manic symptoms in bipolar disorder associated with polymorphisms in the DAOA and COMT genes. PLoS One 2013, 8:e67450.
22. Jonsson E.G., Saetre P., Vares M., Andreou D., Larsson K., Timm S., et al. DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study. Neuropsychobiology 2009, 59:142-150.
23. Kessler R.C., Aguilar-Gaxiola S., Alonso J., Chatterji S., Lee S., Ustun T.B. The WHO World Mental Health (WMH) surveys. Psychiatrie 2009, 6:5-9.
24. Korostishevsky M., Kaganovich M., Cholostoy A., Ashkenazi M., Ratner Y., Dahary D., et al. Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol Psychiatry 2004, 56:169-176.
25. Lee S.Y., Chen S.L., Chang Y.H., Chu C.H., Huang S.Y., Tzeng N.S., et al. The ALDH2 and 5-HT2A genes interacted in bipolar-I but not bipolar-II disorder. Prog Neuropsychopharmacol Biol Psychiatry 2012, 38:247-251.
26. Li D., He L. G72/G30 genes and schizophrenia: a systematic meta-analysis of association studies. Genetics 2007, 175:917-922.
27. Li Y., Jing-ru S., Ye R., Yanrui W., Liguo Z., Yonghui Z., et al. Association of d-amino acid oxidase activator gene polymorphisms with schizophrenia in a Chinese Han sample. Chin J Psychiatry 2011, 44:70-76.
28. Lichtenstein P., Yip B.H., Bjork C., Pawitan Y., Cannon T.D., Sullivan P.F., et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373:234-239.
29. Ma J., Qin W., Wang X.Y., Guo T.W., Bian L., Duan S.W., et al. Further evidence for the association between G72/G30 genes and schizophrenia in two ethnically distinct populations. Mol Psychiatry 2006, 11:479-487.
30. McGuffin P., Rijsdijk F., Andrew M., Sham P., Katz R., Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003, 60:497-502.
31. Merikangas K.R., Jin R., He J.P., Kessler R.C., Lee S., Sampson N.A., et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011, 68:241-251.
32. Muller D.J., Zai C.C., Shinkai T., Strauss J., Kennedy J.L. Association between the DAOA/G72 gene and bipolar disorder and meta-analyses in bipolar disorder and schizophrenia. Bipolar Disord 2011, 13:198-207.
33. Muzina D.J., Kemp D.E., McIntyre R.S. Differentiating bipolar disorders from major depressive disorders: treatment implications. Ann Clin Psychiatry 2007, 19:305-312.
34. Ohi K., Hashimoto R., Yasuda Y., Yoshida T., Takahashi H., Iike N., et al. Association study of the G72 gene with schizophrenia in a Japanese population: a multicenter study. Schizophr Res 2009, 109:80-85.
35. Palomino A., Gonzalez-Pinto A., Aldama A., Gonzalez-Gomez C., Mosquera F., Gonzalez-Garcia G., et al. Decreased levels of plasma glutamate in patients with first-episode schizophrenia and bipolar disorder. Schizophr Res 2007, 95:174-178.
36. Peerbooms O.L., van Os J., Drukker M., Kenis G., Hoogveld L., de Hert M., et al. Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability?. Brain Behav Immun 2011, 25:1530-1543.
37. Prata D.P., Papagni S.A., Mechelli A., Fu C.H., Kambeitz J., Picchioni M., et al. Effect of d-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency. Hum Brain Mapp 2012, 33:143-153.
38. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
39. Rethelyi J.M., Bakker S.C., Polgar P., Czobor P., Strengman E., Pasztor P.I., et al. Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:792-801.
40. Rietschel M., Beckmann L., Strohmaier J., Georgi A., Karpushova A., Schirmbeck F., et al. G72 and its association with major depression and neuroticism in large population-based groups from Germany. Am J Psychiatry 2008, 165:753-762.
41. Sacchetti E., Scassellati C., Minelli A., Valsecchi P., Bonvicini C., Pasqualetti P., et al. Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tag SNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. BMC Med Genet 2013, 14:33.
42. Sanders A.R., Duan J., Levinson D.F., Shi J., He D., Hou C., et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008, 165:497-506.
43. Schultz C.C., Nenadic I., Koch K., Wagner G., Roebel M., Schachtzabel C., et al. Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophrenia. Neuropsychopharmacology 2011, 36:1747-1753.
44. Schulze T.G., Ohlraun S., Czerski P.M., Schumacher J., Kassem L., Deschner M., et al. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes. Am J Psychiatry 2005, 162:2101-2108.
45. Schumacher J., Jamra R.A., Freudenberg J., Becker T., Ohlraun S., Otte A.C., et al. Examination of G72 and d-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 2004, 9:203-207.
46. Seifuddin F., Mahon P.B., Judy J., Pirooznia M., Jancic D., Taylor J., et al. Meta-analysis of genetic association studies on bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2012, 159B:508-518.
47. Shi J., Badner J.A., Gershon E.S., Liu C. Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophr Res 2008, 98:89-97.
48. Shin H.D., Park B.L., Kim E.M., Lee S.O., Cheong H.S., Lee C.H., et al. Association analysis of G72/G30 polymorphisms with schizophrenia in the Korean population. Schizophr Res 2007, 96:119-124.
49. Shinkai T., De Luca V., Hwang R., Muller D.J., Lanktree M., Zai G., et al. Association analyses of the DAOA/G30 and d-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia. Neuromolecular Med 2007, 9:169-177.
50. Soronen P., Mantere O., Melartin T., Suominen K., Vuorilehto M., Rytsala H., et al. P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts. Am J Med Genet B Neuropsychiatr Genet 2011, 156B:435-447.
51. Tsuang H.C., Chen W.J., Lin S.H., Chen T.Y., Chang Y.L., Huang K.H., et al. Impaired impulse control is associated with a 5-HT2A receptor polymorphism in schizophrenia. Psychiatry Res 2013, 208:105-110.
52. Van Snellenberg J.X., de Candia T. Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder. Arch Gen Psychiatry 2009, 66:748-755.
53. Vilella E., Costas J., Sanjuan J., Guitart M., De Diego Y., Carracedo A., et al. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. J Psychiatr Res 2008, 42:278-288.
54. Wang K.S., Liu X.F., Aragam N. A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder. Schizophr Res 2010, 124:192-199.
55. Wang X., He G., Gu N., Yang J., Tang J., Chen Q., et al. Association of G72/G30 with schizophrenia in the Chinese population. Biochem Biophys Res Commun 2004, 319:1281-1286.
56. Williams H.J., Craddock N., Russo G., Hamshere M.L., Moskvina V., Dwyer S., et al. Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Hum Mol Genet 2011, 20:387-391.
57. Williams N.M., Green E.K., Macgregor S., Dwyer S., Norton N., Williams H., et al. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2006, 63:366-373.
58. Wood L.S., Pickering E.H., Dechairo B.M. Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia. Biol Psychiatry 2007, 61:1195-1199.
59. Yang L., Shao J.R., Ruan Y., Wu Y.R., Zhou L.G., Zhang Y.H., et al. Association of D-amino acid oxidase activator gene polymorphisms with schizophrenia in a Chinese Han sample. Chin J Psychiatry. 2011, 44:70-75.
60. Yue W., Kang G., Zhang Y., Qu M., Tang F., Han Y., et al. Association of DAOA polymorphisms with schizophrenia and clinical symptoms or therapeutic effects. Neurosci Lett 2007, 416:96-100.
61. Zhang Z., Li Y., Zhao Q., Huang K., Wang P., Yang P., et al. First evidence of association between G72 and bipolar disorder in the Chinese Han population. Psychiatr Genet 2009, 19:151-153.
62. Zuliani R., Moorhead T.W., Job D., McKirdy J., Sussmann J.E., Johnstone E.C., et al. Genetic variation in the G72 (DAOA) gene affects temporal lobe and amygdala structure in subjects affected by bipolar disorder. Bipolar Disord 2009, 11:621-627.